This inventor holds 1 USPTO granted patent. Top assignees: Mitsubishi Pharma Corporation, University of Virginia Patent Foundation. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2010
Title: Hajime Tei: Innovator in Circadian Rhythm Research
Introduction
Hajime Tei is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of genetic engineering, particularly in the study of circadian rhythms. His work has implications for understanding various diseases and disorders related to these biological cycles.
Latest Patents
Hajime Tei holds a patent for a groundbreaking invention titled "Transgenic mammals introduced a Period 1 promoter that confers rhythmical expression." This invention relates to an isolated Period 1 (Per1) promoter DNA that induces rhythmical expression of a gene operably linked to it. The patent also encompasses a DNA comprising a Period 1 promoter DNA and a gene under its regulation. Furthermore, it provides transformants and transgenic mammals into which this DNA has been introduced. These transformants and transgenic mammals are valuable for screening pharmaceutical drugs aimed at treating diseases associated with circadian rhythm disruptions. He has 1 patent to his name.
Career Highlights
Throughout his career, Hajime Tei has worked with prominent organizations, including Mitsubishi Pharma Corporation and the University of Virginia Patent Foundation. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Hajime Tei has collaborated with esteemed colleagues such as Michikazu Abe and Yoshiyuki Sakaki. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Hajime Tei's innovative work in the field of circadian rhythms exemplifies the importance of genetic research in addressing health issues. His contributions continue to influence the scientific community and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile